Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CAM Researcher Qualifications Review by IoM Cmte. Urged by Straus

This article was originally published in The Tan Sheet

Executive Summary

The Institute of Medicine's Committee on the Use of Complementary & Alternative Medicine by the American Public should evaluate the different qualifications and knowledge sets CAM researchers bring to the study environment, NCCAM Director Stephen Straus, MD, said at the group's inaugural meeting in Washington, D.C. Feb. 27

You may also be interested in...



Botanical Monographs, Marketing Exclusivity Discussed By IoM Committee

Botanical products should either conform to established monographs or be subjected to clinical trials that prove their safety and efficacy, health policy analyst Rowena Richter said at an IoM Committee meeting on U.S. consumers' use of complementary & alternative medicine held in Washington, D.C. June 30

Botanical Monographs, Marketing Exclusivity Discussed By IoM Committee

Botanical products should either conform to established monographs or be subjected to clinical trials that prove their safety and efficacy, health policy analyst Rowena Richter said at an IoM Committee meeting on U.S. consumers' use of complementary & alternative medicine held in Washington, D.C. June 30

Botanical Monographs, Marketing Exclusivity Discussed By IoM Committee

Botanical products should either conform to established monographs or be subjected to clinical trials that prove their safety and efficacy, health policy analyst Rowena Richter said at an IoM Committee meeting on U.S. consumers' use of complementary & alternative medicine held in Washington, D.C. June 30

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095175

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel